KR950013562B1 - 콜린에스테라제 억제제로서의 삼환-환상 아민 유도체 - Google Patents
콜린에스테라제 억제제로서의 삼환-환상 아민 유도체 Download PDFInfo
- Publication number
- KR950013562B1 KR950013562B1 KR1019910002113A KR910002113A KR950013562B1 KR 950013562 B1 KR950013562 B1 KR 950013562B1 KR 1019910002113 A KR1019910002113 A KR 1019910002113A KR 910002113 A KR910002113 A KR 910002113A KR 950013562 B1 KR950013562 B1 KR 950013562B1
- Authority
- KR
- South Korea
- Prior art keywords
- piperidinyl
- phenylmethyl
- methyl
- indol
- pyrrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47692890A | 1990-02-08 | 1990-02-08 | |
US476,928 | 1990-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910015580A KR910015580A (ko) | 1991-09-30 |
KR950013562B1 true KR950013562B1 (ko) | 1995-11-09 |
Family
ID=23893824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910002113A KR950013562B1 (ko) | 1990-02-08 | 1991-02-07 | 콜린에스테라제 억제제로서의 삼환-환상 아민 유도체 |
Country Status (21)
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
EP0475908A1 (de) * | 1990-09-14 | 1992-03-18 | Ciba-Geigy Ag | Chromogene Lactamverbindungen und ihre Herstellung und Verwendung |
TW263504B (US20100056889A1-20100304-C00004.png) * | 1991-10-03 | 1995-11-21 | Pfizer | |
TW248556B (US20100056889A1-20100304-C00004.png) * | 1993-01-18 | 1995-06-01 | Takeda Pharm Industry Co | |
US5620973A (en) * | 1993-11-30 | 1997-04-15 | Takeda Chemical Industries, Ltd. | Tetracyclic condensed heterocyclic compounds and their use |
AU758802B2 (en) | 1998-09-30 | 2003-03-27 | Takeda Pharmaceutical Company Limited | Drugs for improving vesical excretory strength |
US7618979B2 (en) * | 2002-10-30 | 2009-11-17 | Merck Frosst Canada Ltd. | Pyridopyrrolizine and pyridoindolizine derivatives |
US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
WO2012038966A1 (en) | 2010-09-22 | 2012-03-29 | Tyche Industries Ltd. | Process for the preparation of donepezil intermediate |
MA50093B1 (fr) * | 2017-09-07 | 2022-05-31 | Eisai R&D Man Co Ltd | Composé pentacyclique |
EA202191966A1 (ru) | 2019-03-05 | 2021-12-08 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Пентациклическое гетероциклическое соединение |
AU2020233452A1 (en) | 2019-03-05 | 2021-09-02 | Eisai R&D Management Co., Ltd. | Salt of pentacyclic compound and crystals thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3910947A (en) * | 1969-07-24 | 1975-10-07 | Sandoz Ag | Preparation of imidazo{8 2,1-a{9 isoindoles |
IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
US4563469A (en) * | 1984-07-20 | 1986-01-07 | Warner-Lambert Company | Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators |
EP0187619A3 (de) * | 1985-01-03 | 1987-08-26 | Ciba-Geigy Ag | 1,3-disubstituierte Tetrahydropyridine |
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
US4778812A (en) * | 1987-06-12 | 1988-10-18 | American Home Products Corporation | 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof |
EP0351283A1 (fr) * | 1988-07-12 | 1990-01-17 | Synthelabo | Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique |
-
1991
- 1991-01-23 TW TW080100556A patent/TW197442B/zh active
- 1991-01-29 EP EP19910300662 patent/EP0441517A3/en not_active Withdrawn
- 1991-02-03 IL IL9714091A patent/IL97140A/en not_active IP Right Cessation
- 1991-02-06 DE DE9101348U patent/DE9101348U1/de not_active Expired - Lifetime
- 1991-02-06 PL PL91288977A patent/PL166757B1/pl unknown
- 1991-02-06 PL PL91304632A patent/PL167078B1/pl unknown
- 1991-02-06 CA CA002035805A patent/CA2035805C/en not_active Expired - Fee Related
- 1991-02-06 PT PT96681A patent/PT96681A/pt unknown
- 1991-02-07 IE IE040291A patent/IE910402A1/en unknown
- 1991-02-07 NO NO910473A patent/NO177534C/no unknown
- 1991-02-07 AU AU70879/91A patent/AU631723B2/en not_active Ceased
- 1991-02-07 ZA ZA91916A patent/ZA91916B/xx unknown
- 1991-02-07 NZ NZ237040A patent/NZ237040A/xx unknown
- 1991-02-07 EG EG7591A patent/EG19644A/xx active
- 1991-02-07 BR BR919100519A patent/BR9100519A/pt not_active Application Discontinuation
- 1991-02-07 YU YU21391A patent/YU21391A/sh unknown
- 1991-02-07 FI FI910592A patent/FI910592A/fi not_active Application Discontinuation
- 1991-02-07 CN CN91100860A patent/CN1054600A/zh active Pending
- 1991-02-07 KR KR1019910002113A patent/KR950013562B1/ko active IP Right Grant
- 1991-02-07 HU HU91406A patent/HUT70051A/hu unknown
- 1991-02-07 CS CS91299A patent/CS29991A2/cs unknown
- 1991-02-08 JP JP3103992A patent/JPH07119214B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI910592A (fi) | 1991-08-09 |
JPH04234845A (ja) | 1992-08-24 |
CN1054600A (zh) | 1991-09-18 |
NO910473L (no) | 1991-08-09 |
PL288977A1 (en) | 1992-01-13 |
DE9101348U1 (de) | 1991-06-06 |
ZA91916B (en) | 1992-09-30 |
IE910402A1 (en) | 1991-08-14 |
KR910015580A (ko) | 1991-09-30 |
NO177534B (no) | 1995-06-26 |
NO177534C (no) | 1995-10-04 |
EP0441517A2 (en) | 1991-08-14 |
AU7087991A (en) | 1991-08-29 |
NO910473D0 (no) | 1991-02-07 |
PL166757B1 (pl) | 1995-06-30 |
CA2035805C (en) | 1995-06-27 |
EP0441517A3 (en) | 1992-08-19 |
HUT70051A (en) | 1995-09-28 |
HU910406D0 (en) | 1991-08-28 |
YU21391A (sh) | 1994-01-20 |
EG19644A (en) | 1995-08-30 |
PT96681A (pt) | 1991-10-31 |
NZ237040A (en) | 1993-10-26 |
BR9100519A (pt) | 1991-10-29 |
FI910592A0 (fi) | 1991-02-07 |
TW197442B (US20100056889A1-20100304-C00004.png) | 1993-01-01 |
IL97140A (en) | 1995-07-31 |
CS29991A2 (en) | 1991-09-15 |
JPH07119214B2 (ja) | 1995-12-20 |
PL167078B1 (pl) | 1995-07-31 |
IL97140A0 (en) | 1992-05-25 |
AU631723B2 (en) | 1992-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5100902A (en) | 1,2-benzisoxazole compounds | |
US7238690B2 (en) | Substituted heterocycle fused gamma-carbolines | |
JP2634190B2 (ja) | 新環状アミン誘導体及びこれらの化合物を含む薬学的組成物 | |
CA2432181C (en) | Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists | |
KR950013562B1 (ko) | 콜린에스테라제 억제제로서의 삼환-환상 아민 유도체 | |
JPH11502861A (ja) | サブスタンスpアンタゴニストとしての置換ベンゾラクタム化合物 | |
SK281748B6 (sk) | Použitie piperidínových derivátov na výrobu farmaceutických prostriedkov, piperidínové deriváty a farmaceutické prostriedky | |
JPH08225569A (ja) | ベンジルピペリジン誘導体 | |
EP0606248A1 (en) | Heteroaryl amines as novel acetyl cholinesterase inhibitors | |
AU716435B2 (en) | Novel indole-2,3-dione-3-oxime derivatives | |
HU198931B (en) | Process for producing 2-square brackets open /piperidin-4-yl/-methyl square brackets closed -1,2,3,4-tetradihydro-9h-pyrido/3,4-b/indole derivatives and pharma ceutical compositions comprising same | |
JP2006522065A (ja) | 5−ht2c受容体活性を有する化合物およびその使用 | |
EP0638571A1 (en) | Quinoline derivative or salt thereof and remedy for cardiac diseases containing the same | |
US4420485A (en) | 1'-[3-(1,2-Benzisoxazol-3-yl) proply]spiro[benzofuran-2(3H),3' or 4'-piperidines or 3'-pyrrolidines] | |
US20040053956A1 (en) | Isoquinoline derivatives useful in the treatment of cns disorders | |
EP0412822B1 (en) | 4,4-Disubstituted piperidine derivatives, processes for their preparation and pharmaceutical compositions thereof | |
US4268513A (en) | Pyrrolo [3,4-c]quinoline compounds and pharmaceutical compositions, methods for their use and preparation | |
EP0670313A1 (en) | Spiro compounds, their production and use | |
ES2211520T3 (es) | Compuestos de benzolactama sustituidos. | |
US5428043A (en) | Tricyclic-cyclic amines as novel cholinesterase inhibitors | |
US4409229A (en) | Antidepressive and tranquilizing substituted 1,3-dihydrospiro[benzo(c)thiophene]s | |
WO2001014384A1 (fr) | Derives dihydrobenzofuran tricycliques, leur procede de preparation et agents | |
EP0538314A1 (en) | INDIANO-PYRROLIDINE CARBAMATES. | |
US6288225B1 (en) | Substituted benzolactam compounds as substance P antagonists | |
CA1108156A (en) | Phenanthrene derivatives, their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E801 | Decision on dismissal of amendment | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
G160 | Decision to publish patent application | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |